v3.7.0.1
CONDENSED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Operating expenses:        
Research and development $ 1,339,039 $ 1,153,043 $ 2,677,643 $ 1,579,157
General and administrative 1,676,336 4,380,540 3,233,677 6,266,000
Depreciation 2,997 2,333 6,066 5,241
Total operating expenses 3,018,372 5,535,916 5,917,386 7,850,398
Loss from operations (3,018,372) (5,535,916) (5,917,386) (7,850,398)
Other income (expense):        
Loss on change in fair value of derivatives (60,244) (556,433) (433,855) (824,858)
Interest income 54 1 54 1
Loss before income taxes (3,078,562) (6,092,348) (6,351,187) (8,675,255)
Income taxes (benefit) 0 0 0 0
Net loss (3,078,562) (6,092,348) (6,351,187) (8,675,255)
Preferred stock dividend (22,863) (28,497) (46,608) (60,741)
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS $ (3,101,425) $ (6,120,845) $ (6,397,795) $ (8,735,996)
Net loss per common share, basic and diluted (in Dollars per share) $ (0.12) $ (0.32) $ (0.27) $ (0.49)
Weighted average number of common shares outstanding, basic and diluted (in Shares) 25,131,486 18,875,819 24,097,424 17,971,228

Source